Catherine Vilchèze

9.1k total citations
85 papers, 6.3k citations indexed

About

Catherine Vilchèze is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Catherine Vilchèze has authored 85 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Infectious Diseases, 59 papers in Epidemiology and 41 papers in Molecular Biology. Recurrent topics in Catherine Vilchèze's work include Tuberculosis Research and Epidemiology (62 papers), Mycobacterium research and diagnosis (50 papers) and Antibiotic Resistance in Bacteria (15 papers). Catherine Vilchèze is often cited by papers focused on Tuberculosis Research and Epidemiology (62 papers), Mycobacterium research and diagnosis (50 papers) and Antibiotic Resistance in Bacteria (15 papers). Catherine Vilchèze collaborates with scholars based in United States, France and Canada. Catherine Vilchèze's co-authors include William R. Jacobs, Robert Bittman, James C. Sacchettini, Laurent Kremer, Brian Weinrick, Travis Hartman, Torin R. Weisbrod, David Alland, Manzour Hernando Hazbón and Guy Duportail and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Catherine Vilchèze

83 papers receiving 6.2k citations

Peers

Countries citing papers authored by Catherine Vilchèze

Since Specialization

Citations

This map shows the geographic impact of Catherine Vilchèze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Vilchèze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Vilchèze more than expected).

Fields of papers citing papers by Catherine Vilchèze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Vilchèze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Vilchèze. The network helps show where Catherine Vilchèze may publish in the future.

Co-authorship network of co-authors of Catherine Vilchèze

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Vilchèze. A scholar is included among the top collaborators of Catherine Vilchèze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Vilchèze. Catherine Vilchèze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion 2025 ·Proceedings of the National Academy of Sciences ·(unknown), Rajagopalan Saranathan, (unknown), Shichun Lun, Catherine Vilchèze, (unknown), Manish Gupta, (unknown), William R. Bishai, William R. Jacobs	1
2	Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates 2024 ·The Journal of Infectious Diseases ·Rajagopalan Saranathan, (unknown), (unknown), Donna Kohlerschmidt, (unknown), (unknown), (unknown), Catherine Vilchèze, (unknown), Sashen Moodley, (unknown), Jared S. Mackenzie, Adrie J. C. Steyn, Rubeshan Perumal, Michael Berney, Michelle H. Larsen, Max R. O’Donnell, Vincent Escuyer, William R. Jacobs	3
3	Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), Catherine Vilchèze, Jim Werngren, Arnold Bainomugisa, Mikael Mansjö, Ramona Groenheit, Paolo Miotto, Daniela María Cirillo, Christopher Coulter, Alain R. Baulard, Thomas Schön, William R. Jacobs, (unknown), Claudio U. Köser	2
4	The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis 2019 ·Journal of Molecular Biology ·Catherine Vilchèze, William R. Jacobs	102
5	Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis 2017 ·Proceedings of the National Academy of Sciences ·Catherine Vilchèze, Travis Hartman, Brian Weinrick, Paras Jain, Torin R. Weisbrod, Lawrence W. Leung, Joel S. Freundlich, William R. Jacobs	135
6	Mycobacterium tuberculosis universal stress protein Rv2623 interacts with the putative ATP binding cassette (ABC) transporter Rv1747 to regulate mycobacterial growth 2017 ·PLoS Pathogens ·(unknown), (unknown), Sivagami Sundaram Chavadi, JoAnn M. Tufariello, Kaixia Mi, (unknown), TuKiet T. Lam, Guofeng Zhu, Chenyang Zhan, Catherine Vilchèze, Jesús Arcos, Yong Chen, Lijun Bi, Simren Mehta, Steven A. Porcelli, S.C. Almo, Syun‐Ru Yeh, William R. Jacobs, Jordi B. Torrelles, John Chan	41
7	Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights 2015 ·Tetrahedron Letters ·Shao-Gang Li, Catherine Vilchèze, Sumit Chakraborty, Xin Wang, Hiyun Kim, (unknown), Sean Ekins, Kyu Y. Rhee, William R. Jacobs, Joel S. Freundlich	28
8	Succinate Dehydrogenase is the Regulator of Respiration in Mycobacterium tuberculosis 2014 ·PLoS Pathogens ·Travis Hartman, Brian Weinrick, Catherine Vilchèze, Michael Berney, (unknown), Gregory M. Cook, William R. Jacobs	74
9	Phosphorylation of KasB Regulates Virulence and Acid-Fastness in Mycobacterium tuberculosis 2014 ·PLoS Pathogens ·Catherine Vilchèze, Virginie Molle, Séverine Carrère‐Kremer, Jade Leiba, Lionel Mourey, Shubhada Shenai, Grégory Baronian, JoAnn M. Tufariello, Travis Hartman, Romain Veyron‐Churlet, Xavier Trivelli, Sangeeta Tiwari, Brian Weinrick, David Alland, Yann Guérardel, William R. Jacobs, Laurent Kremer	54
10	Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains 2012 ·Antimicrobial Agents and Chemotherapy ·(unknown), Catherine Vilchèze, (unknown), William R. Jacobs, Santiago Ramón‐García, Charles J. Thompson	104
11	Einstein Contained Aerosol Pulmonizer (ECAP): Improved Biosafety for Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) Mycobacterium tuberculosis Aerosol Infection Studies 2011 ·Applied Biosafety ·Bing Chen, Torin R. Weisbrod, Tsungda Hsu, Vasan K. Sambandamurthy, (unknown), (unknown), (unknown), (unknown), W. Emmett Barkley, Catherine Vilchèze, (unknown), David S. Thaler, Michelle H. Larsen, A. Willem Sturm, William R. Jacobs	4
12	Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis 2008 ·Molecular Microbiology ·Catherine Vilchèze, Yossef Av‐Gay, Rodgoun Attarian, Zhen Liu, Manzour Hernando Hazbón, Roberto Colangeli, Bing Chen, Weijun Liu, David Alland, James C. Sacchettini, William R. Jacobs	124
13	Dual Inhibition of Mycobacterial Fatty Acid Biosynthesis and Degradation by 2-Alkynoic Acids 2006 ·Chemistry & Biology ·Héctor R. Morbidoni, Catherine Vilchèze, Laurent Kremer, Robert Bittman, James C. Sacchettini, William R. Jacobs	44
14	Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid 2006 ·Nature Medicine ·Catherine Vilchèze, Feng Wang, Masayoshi Arai, Manzour Hernando Hazbón, Roberto Colangeli, Laurent Kremer, Torin R. Weisbrod, David Alland, James C. Sacchettini, William R. Jacobs	235
15	Bxz1, a new generalized transducing phage for mycobacteria 2004 ·FEMS Microbiology Letters ·Sunhee Lee, Jordan Kriakov, Catherine Vilchèze, (unknown), Graham F. Hatfull, William R. Jacobs	42
16	Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria 2003 ·Journal of Biological Chemistry ·Laurent Kremer, Lynn G. Dover, Héctor R. Morbidoni, Catherine Vilchèze, (unknown), Alain R. Baulard, Shiao‐Chun Tu, Nadine Honoré, Vojo Deretić, James C. Sacchettini, Camille Locht, William R. Jacobs, Gurdyal S. Besra	56
17	Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis 2002 ·Molecular Microbiology ·Michelle H. Larsen, Catherine Vilchèze, Laurent Kremer, Gurdyal S. Besra, Linda M. Parsons, Max Salfinger, Leonid Heifets, Manzour Hernando Hazbón, David Alland, James C. Sacchettini, William R. Jacobs	149
18	Effect of the Structure of Natural Sterols and Sphingolipids on the Formation of Ordered Sphingolipid/Sterol Domains (Rafts) 2001 ·Journal of Biological Chemistry ·(unknown), Robert Bittman, Guy Duportail, Denis Heissler, Catherine Vilchèze, Erwin London	459
19	The effect of side-chain analogues of cholesterol on the thermotropic phase behavior of 1-stearoyl-2-oleoylphosphatidylcholine bilayers: a differential scanning calorimetric study 1996 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Catherine Vilchèze, Todd McMullen, Ronald N. McElhaney, Robert Bittman	57
20	Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis 1995 ·Biochemistry ·Annaı̈k Quémard, James C. Sacchettini, Andréa Dessen, Catherine Vilchèze, Robert Bittman, William R. Jacobs, John S. Blanchard	298

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact